Literature DB >> 11444399

Awake craniotomy for aggressive resection of primary gliomas located in eloquent brain.

F B Meyer1, L M Bates, S J Goerss, J A Friedman, W L Windschitl, J R Duffy, W J Perkins, B P O'Neill.   

Abstract

OBJECTIVE: To determine with intraoperative neurologic and language examinations the maximal tumor resection achievable with acceptable postoperative neurologic dysfunction in patients undergoing awake stereotactic glial tumor resection in eloquent regions of the brain. PATIENTS AND METHODS: Between October 1995 and December 2000, 65 patients underwent frameless stereotactic resection of glial tumors located in functioning tissue. During the resection, continuous examinations by a neurologist and speech pathologist were performed. The goal of surgery was to resect the maximum neurologically permissible tumor volume defined on preoperative T2 imaging. Tumor resection was stopped at the onset of neurologic dysfunction. Novel segmentation software was used to measure tumor cytoreduction based on pre- and postoperative magnetic resonance imaging. All patients underwent 3-month postoperative neurologic examinations to determine functional outcomes.
RESULTS: The cortical and subcortical white matter tracts at risk for injury were the left frontal operculum in 15 patients, the central lobule in 38, the insula in 11, and the left angular gyrus in 1. Thirty-four (52%) had a greater than 90% reduction in T2 signal postoperatively. In 26 patients thought to have low-grade tumors based on preoperative imaging, 12 proved to have grade 3 gliomas. Forty-eight patients (74%) developed intraoperative deficits; 34 (71%) recovered to a modified Rankin grade of 0 or 1 at 3 months postoperatively, 11 (23%) achieved a modified Rankin grade of 2, and 3 patients (6%) achieved a modified Rankin grade of 3 or 4 at 3-month follow-up. There was no operative mortality; 17 patients (26%) died from tumor progression during the follow-up period.
CONCLUSIONS: Combining frameless computer-guided stereotaxis with cortical stimulation and repetitive neurologic and language assessments facilitates tumor resection in functioning brain regions. Resecting tumor until the onset of neurologic deficits allows for a good functional recovery. Imaging software can objectively and accurately measure preoperative and postoperative tumor volumes.

Entities:  

Mesh:

Year:  2001        PMID: 11444399     DOI: 10.4065/76.7.677

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  30 in total

1.  Population-based survival data for brain tumors in Korea.

Authors:  Kyu-Won Jung; Heon Yoo; Hyun-Joo Kong; Young-Joo Won; Sohee Park; Seung Hoon Lee
Journal:  J Neurooncol       Date:  2012-06-04       Impact factor: 4.130

2.  Functional recovery after surgical resection of low grade gliomas in eloquent brain: hypothesis of brain compensation.

Authors:  H Duffau; L Capelle; D Denvil; N Sichez; P Gatignol; M Lopes; M-C Mitchell; J-P Sichez; R Van Effenterre
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-07       Impact factor: 10.154

3.  [Surgical intervention in patients with malignant glioma].

Authors:  Herwig Kostron; Karl Rössler
Journal:  Wien Med Wochenschr       Date:  2006-06

Review 4.  Intraoperative neurological monitoring in awake craniotomy.

Authors:  Kiyotaka Sato; Masato Kato
Journal:  J Anesth       Date:  2008-11-15       Impact factor: 2.078

Review 5.  Awake surgery between art and science. Part I: clinical and operative settings.

Authors:  Andrea Talacchi; Barbara Santini; Francesca Casagrande; Franco Alessandrini; Giada Zoccatelli; Giovanna M Squintani
Journal:  Funct Neurol       Date:  2013 Jul-Sep

Review 6.  Image guidance and neuromonitoring in neurosurgery.

Authors:  Wai Hoe Ng; Karim Mukhida; James T Rutka
Journal:  Childs Nerv Syst       Date:  2010-02-20       Impact factor: 1.475

7.  Outcome prediction in intracranial tumor surgery: the National Surgical Quality Improvement Program 2005-2010.

Authors:  Kimon Bekelis; Samuel F Bakhoum; Atman Desai; Todd A Mackenzie; David W Roberts
Journal:  J Neurooncol       Date:  2013-02-24       Impact factor: 4.130

8.  Improved survival time trends for glioblastoma using the SEER 17 population-based registries.

Authors:  Matthew Koshy; John L Villano; Therese A Dolecek; Andrew Howard; Usama Mahmood; Steven J Chmura; Ralph R Weichselbaum; Bridget J McCarthy
Journal:  J Neurooncol       Date:  2011-10-09       Impact factor: 4.130

9.  Association between hospital volume and receipt of treatment and survival in patients with glioblastoma.

Authors:  Matthew Koshy; David J Sher; Michael Spiotto; Zain Husain; Herb Engelhard; Konstantin Slavin; Martin K Nicholas; Ralph R Weichselbaum; Chad Rusthoven
Journal:  J Neurooncol       Date:  2017-08-23       Impact factor: 4.130

Review 10.  Awake craniotomy for supratentorial gliomas: why, when and how?

Authors:  George M Ibrahim; Mark Bernstein
Journal:  CNS Oncol       Date:  2012-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.